v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Redeemable Preferred Stock
January Public Offering
Public Offering
February Public Offering and Leavitt Private Placement
November Private Placement
Common Stock
Common Stock
January Public Offering
Common Stock
Public Offering
Common Stock
February Public Offering and Leavitt Private Placement
Common Stock
November Private Placement
Additional Paid-in Capital
Additional Paid-in Capital
January Public Offering
Additional Paid-in Capital
Public Offering
Additional Paid-in Capital
February Public Offering and Leavitt Private Placement
Additional Paid-in Capital
November Private Placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ (71,297)           $ 2         $ 143,010         $ 700 $ (215,009)
Beginning Balance (in shares) at Dec. 31, 2023             1,907,529                      
Exercise of stock options 25                     25            
Exercise of stock options, (in shares)             649                      
Issuance of common stock for the exercise of warrants 1                     1            
Issuance of common stock for the exercise of warrants (in shares)             13                      
Issuance of common stock from equity line financing 1,007     $ 5,066         $ 1     1,007   $ 5,065        
Issuance of common stock from equity line financing (in shares)             75,618   653,351                  
Issuance of common stock in connection with vesting of RSU awards (in shares)             13,040                      
Stock-based compensation expense 3,056                     3,056            
Issuance of preferred stock in connection with Private Placement, net of issuance costs   $ 979                                
Issuance of preferred stock in connection with Private Placement, net of issuance costs (in shares)   2,260,159                                
Exercise of PIPE Conversion Option (547)                     (547)            
Exercise of PIPE Conversion Option (in shares)             (30,000)                      
Issuance of value common stock for conversion of preferred stock 979 $ (979)                   979            
Issuance of shares common stock for conversion of preferred stock ( in shares)   (2,260,159)         90,407                      
Other comprehensive income (loss) (9,070)                               (9,070)  
Net income (loss) (7,198)                                 (7,198)
Ending Balance at Dec. 31, 2024 (77,978)           $ 3         152,596         (8,370) (222,207)
Ending Balance (in shares) at Dec. 31, 2024             2,710,607                      
Issuance of common stock from equity line financing 794                     794            
Issuance of common stock from equity line financing (in shares)             302,418                      
Issuance of common stock in connection with vesting of RSU awards (in shares)             33,498                      
Stock-based compensation expense 3,146                     3,146            
Issuance of common stock in connection with RTW Private Placement, net of issuance costs 2,500                     2,500            
Issuance of common stock in connection with RTW Private Placement, net of issuance costs, Shares             841,751                      
Issuance of common stock for the conversion of convertible notes 6,585                     6,585            
Issuance of common stock for the conversion of convertible notes (in shares)             2,985,078                      
Issuance of common stock to consultants (in shares)             4,131                      
Issuance of common stock to consultants 6                     6            
Issuance of shares common stock in connection with public offering, net of issuance costs ( in shares)               1,240,000   1,167,686 2,994,012              
Issuance of value common stock in connection with public offering, net of issuance costs     $ 1,227   $ 449 $ 1,327   $ 1   $ 1 $ 1   $ 1,226   $ 448 $ 1,326    
Other comprehensive income (loss) 13,510                               13,510  
Net income (loss) (28,755)                                 (28,755)
Ending Balance at Dec. 31, 2025 $ (77,189)           $ 6         $ 168,627         $ 5,140 $ (250,962)
Ending Balance (in shares) at Dec. 31, 2025             12,279,181